Canaccord Lifts PT on AdaptHealth Corp. (AHCO) Following Q1 Results

AdaptHealth Corp. (NASDAQ:AHCO) is one of the best healthcare stocks to buy for the long term. Canaccord lifted the price target on AdaptHealth Corp. (NASDAQ:AHCO) to $16 from $14 on May 7, reiterating a Buy rating on the shares. The firm updated its model after the company released its fiscal Q1 results, where EBITDA missed estimates and caused a pullback in the shares. It added that AdaptHealth Corp. (NASDAQ:AHCO) appears to be uniquely positioned in the DME market to gain share, especially if the demand environment for capitated agreements becomes the preferred method to better serve patients with chronic conditions.

AdaptHealth Corp. (NASDAQ:AHCO) released its fiscal Q1 2026 results on May 5, with net revenue for the quarter coming up to $819.8 million compared to $777.9 million, reflecting an increase of 5.4%. The company also reported organic revenue growth of 9.1%, with growth across each of the reportable segments. Net loss attributable to the company was $16.0 million.

AdaptHealth Corp. (NASDAQ:AHCO) provides home healthcare equipment, supplies, and related services. The company’s focus is on sleep therapy equipment for obstructive sleep apnea, oxygen, and related chronic therapy services, HME medical devices and supplies for wound care, diabetes, urological, and more.

While we acknowledge the risk and potential of AHCO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AHCO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.